(Q35114389)

6 August 2017

1 reference

title

Thrombospondins 1 and 2 function as inhibitors of angiogenesis (English)

1 reference

6 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714043

27 December 2023

author name string

Paul Bornstein

2

1 reference

6 August 2017

Lucas C. Armstrong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714043

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714043

27 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0945053X03000052?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

https://api.elsevier.com/content/article/PII:S0945053X03000052?httpAccept=text/plain

27 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

27 December 2023

1 reference

6 August 2017

volume

22

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

63-71

1 reference

Thrombospondins: multifunctional regulators of cell interactions

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondins as matricellular modulators of cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

1 reference

7 January 2021

Matricellular proteins: extracellular modulators of cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Endogenous angiogenesis inhibitors and their therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondins and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

C-mannosylation and O-fucosylation of the thrombospondin type 1 module

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Normoxic wound fluid contains high levels of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Altered extracellular matrix remodeling and angiogenesis in sponge granulomas of thrombospondin 2-null mice

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Tumstatin, an endothelial cell-specific inhibitor of protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Xenopus kielin: A dorsalizing factor containing multiple chordin-type repeats secreted from the embryonic midline.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Inhibition of angiogenesis by thrombospondin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

1 reference

https://api.crossref.org/works/10.1016%2FS0945-053X%2803%2900005-2

7 January 2021

Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells

23

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

Reduced angiogenesis and tumor progression in gelatinase A-deficient mice

27 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms

27 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing

27 December 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor

27 December 2023

55

1 reference

https://api.crossref.org/works/10.1016/S0945-053X(03)00005-2

27 December 2023

Identifiers

1 reference

6 August 2017

1 reference